Skip to content
Medical Health Aged Care

RACGP welcomes reforms reducing admin burden on GPs

Royal Australian College of GPs 2 mins read

Australia’s peak GP body has welcomed the Senate passing reforms modernising the process for GPs to document patient consent for bulk billing benefits to be paid to their health provider. 

Under the old legislation, patients had to physically sign to consent for bulk billing benefits to be paid directly to their GP or other health provider. The Health Insurance Legislation Amendment (Assignment of Medicare Benefits) Bill 2024, which passed today, will enable a digital solution for documenting consent, and streamline the process. 

Royal Australian College of GPs (RACGP) President Dr Nicole Higgins welcomed the reforms. 

“I applaud Senators for acting on the RACGP’s calls for change and passing these reforms – it will give GPs more time to spend on patient care,” she said. 

“Removing the need for a physical signature will also make the process simpler and more convenient for patients, particularly those who are vulnerable. 

“Reducing the complexity of Medicare is a priority for RACGP advocacy. The regulatory burden on GPs is immense – our annual Health of the Nation report has found GPs are increasingly reporting the administrative workload and associated stress among their greatest concerns. 

“I look forward to continuing to work with the government to reduce the red tape and administrative burden on GPs and practice teams, so we have more time to spend caring for patients and communities.” 

~ENDS


About us:

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians.

Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here.


Contact details:

John Ronan
Media Adviser

Ally Francis
Media Adviser

Stuart Winthrope
Media Officer

Contact: 03 8699 0992[email protected]

Follow us on Twitter: @RACGP and Facebook.

More from this category

  • Biotechnology, Medical Health Aged Care
  • 10/04/2026
  • 11:12
Aravax

Aravax Strengthens Board with Appointments of Carsten Hellmann and Andrew Oxtoby

Aravax, a clinical-stage biotechnology company developing next-generation, disease-modifyingimmunotherapies for food allergy, today announces two additions to its Board of Directors, former CEO of ALK-Abello A/S, Carsten Hellmann and former Chief Commercial Officer of Aimmune Therapeutics, Andrew Oxtoby. Collectively, Carsten and Andrew bring to Aravax exceptionally deep experience from the pharmaceutical industry and, specifically, the allergy therapeutics field. Andrew has deep pharmaceutical industry expertise spanning development, product launch, fundraising and exits from working with large and small companies in the U.S. and Europe. As Chief Commercial Officer he built the global commercial organisation for the approval and launch in the US…

  • Medical Health Aged Care, Political
  • 10/04/2026
  • 09:25
McKell Institute

Australians skipping doses, taking expired medication as prices balloon despite ‘Cheaper Medicines’

Australians are skipping doses, taking expired medication and going without groceries to afford medicines prescribed by their doctors because they aren’t covered by Labor’s landmark Cheaper Medicines policy, new research from the McKell Institute has revealed. McKell’s new report Still Out of Pocket found 43 per cent of Australians have been prescribed medicines which aren’t on the PBS. The Cheaper Medicines policy only covers medicines listed on the PBS. 24 per cent of all people prescribed medicines outside the PBS do not purchase the medicine at all, while 16 per cent say they are forced to go without essentials, like…

  • Medical Health Aged Care
  • 10/04/2026
  • 09:00
Neuroscience Research Australia (NeuRA)

EXPERT ALERT: ‘Bridge the Gap’ this World Parkinson’s Day

One Aussie is diagnosed with Parkinson’s Disease every 40 minutes. It’s the fastest growing neurological condition in the world and the second most common in Australia, after dementia. World Parkinson’s Day on 11 April aims to raise awareness of the disease, reduce stigma and advocate for better care and research support. Neuroscience Research Australia (NeuRA) has a team of experts, including clinician researchers, working to improve our understanding, diagnosis and treatment of Parkinson’s. They are available to speak on the importance of World Parkinson’s Day, providing comment on: Current research projects Improving understanding of Parkinson’s Disease, including its symptoms and…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.